Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Japan”

Pembrolizumab Plus Lenvatinib in Unresectable Cutaneous Angiosarcoma PatientsRecruiting
NCT06673628Phase 2Updated Jun 24, 2026
Sponsor: National Cancer Center, Japan
Angiosarcoma of Skin · Angiosarcoma Metastatic
Japan
Safety and Initial Effectiveness of Transcranial MR Guided Focused Ultrasound for the Treatment of Parkinson's DiseaseCompleted
NCT04002596NAUpdated Jun 24, 2026
Sponsor: InSightec
Parkinson Disease
China, Japan
Fractional Flow Reserve Versus Angiography for Treatment-Decision and Evaluation of Significant Left MAIN Coronary Artery DiseaseRecruiting
NCT05829889NAUpdated Jun 24, 2026
Sponsor: Seung-Jung Park
Coronary Artery Disease Left Main · Coronary Artery Disease
Hong Kong, India, Japan, South Korea, Taiwan
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202Active Not Recruiting
NCT06062420Phase 2Updated Jun 24, 2026
Sponsor: GlaxoSmithKline
Neoplasms, Head and Neck
United States, Argentina, Brazil, Canada, Denmark +15 more
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)Active Not Recruiting
NCT04954859Phase 2Updated Jun 24, 2026
Sponsor: GlaxoSmithKline
Hepatitis B
United States, Argentina, Australia, Brazil, Bulgaria +24 more
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Recruiting
NCT06878261Phase 3Updated Jun 24, 2026
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
United States, Argentina, Australia, Belgium, Bulgaria +17 more
A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)Recruiting
NCT07666022Phase 1Updated Jun 24, 2026
Sponsor: University of Shizuoka
Healthy Adult Male · PARKINSON DISEASE (Disorder)
Japan
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseaseRecruiting
NCT06283966Phase 3Updated Jun 24, 2026
Sponsor: AstraZeneca
COPD (Chronic Obstructive Pulmonary Disease)
United States, Argentina, Australia, Austria, Brazil +32 more
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.Recruiting
NCT06137144Phase 1, Phase 2Updated Jun 24, 2026
Sponsor: AstraZeneca
Lymphoma · Non-Hodgkin Lymphoma · Hodgkin Lymphoma · Peripheral T-cell Lymphoma (PTCL)
United States, Australia, China, France, Germany +5 more
A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)Completed
NCT05084053Phase 3Updated Jun 24, 2026
Sponsor: Takeda
Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) · Multifocal Motor Neuropathy (MMN)
Japan
CoSMAP Trial: SP-EA vs MP-TA Robot-Assisted Radical ProstatectomyActive Not Recruiting
NCT07666217N/AUpdated Jun 24, 2026
Sponsor: Intuitive Surgical
Prostate Cancer
Japan
A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseActive Not Recruiting
NCT05280548Phase 3Updated Jun 24, 2026
Sponsor: Sanofi
Fabry Disease
United States, Austria, Canada, China, Czechia +14 more
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid ArthritisRecruiting
NCT07276581Phase 2Updated Jun 24, 2026
Sponsor: AstraZeneca
Rheumatoid Arthritis
United States, Argentina, Brazil, Bulgaria, Canada +12 more
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting
NCT06332534Phase 3Updated Jun 24, 2026
Sponsor: AbbVie
Crohn's Disease
United States, Australia, Belgium, Brazil, Bulgaria +13 more
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSDActive Not Recruiting
NCT05346354Phase 2, Phase 3Updated Jun 24, 2026
Sponsor: Alexion Pharmaceuticals, Inc.
Neuromyelitis Optica Spectrum Disorder
United States, Canada, France, Italy, Japan +2 more
A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2Active Not Recruiting
NCT06072183Phase 3Updated Jun 24, 2026
Sponsor: Pfizer
Stable Nonsegmental Vitiligo · Active Nonsegmental Vitiligo
United States, Australia, Belgium, Bulgaria, Canada +13 more
A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Completed
NCT05395481Phase 1Updated Jun 24, 2026
Sponsor: Eli Lilly and Company
Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
United States, Japan, Puerto Rico
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisRecruiting
NCT06867094Phase 2Updated Jun 23, 2026
Sponsor: Sanofi
Colitis Ulcerative
United States, Argentina, Australia, Austria, Belgium +17 more
Targeted Microwave Tissue Coagulation for Prostate CancerActive Not Recruiting
NCT06430749NAUpdated Jun 23, 2026
Sponsor: Osamu Ukimura
Prostate Cancer
Japan
A Study of LY4175408 in Participants With Advanced CancerRecruiting
NCT07046923Phase 1Updated Jun 23, 2026
Sponsor: Eli Lilly and Company
Carcinoma, Non-Small-Cell Lung · Small Cell Lung Carcinoma · Endometrial Neoplasms · Neoplasm Metastasis
United States, China, France, Japan, South Korea +1 more
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or LamotrigineRecruiting
NCT07140913Phase 3Updated Jun 23, 2026
Sponsor: Bristol-Myers Squibb
Mania · Bipolar Disorder
United States, Argentina, Bulgaria, China, Denmark +8 more
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab AdizutecanRecruiting
NCT05005403Phase 1Updated Jun 23, 2026
Sponsor: AbbVie
Non-Small Cell Lung Cancer · Head and Neck Squamous Cell Carcinoma · Micro Satellite Stable Colorectal Cancer · Gastric/Esophageal Cancer
United States, Canada, Israel, Japan, South Korea +1 more
Open-label Extension Study of Brazikumab in Ulcerative ColitisTerminated
NCT04277546Phase 2Updated Jun 23, 2026
Sponsor: AstraZeneca
Ulcerative Colitis
United States, Czechia, Germany, Israel, Italy +6 more
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)Completed
NCT04123366Phase 2Updated Jun 23, 2026
Sponsor: Merck Sharp & Dohme LLC
Solid Tumors
United States, Argentina, Australia, Canada, Colombia +18 more
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)Active Not Recruiting
NCT05555732Phase 3Updated Jun 23, 2026
Sponsor: Daiichi Sankyo
Metastatic Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +24 more

Previous page Next page